| 1/27 | US=90 / Câncer Harrison S. Perspective on the history of tumor models. In: Teicher BA. Tumor models in cancer research. New Jersey: Humana press, 2002. p. 3-19. MODELOS DE TUMOR/COMPORTAMENTO; CURA DA LEUCEMIA EM CRIANCA; CITORREDUCAO EM TUMORES SOLIDOS; PERSPECTIVA EM PREDITIVE; TERAPIA DO CANCER |
| 2/27 | US=8 / Cab/Pescoço Gustman RB, Wood AH. Mechanisms of immune evasion of head and neck cancer. In: Snow JB Jr, Wackym PA. Ballenger's otorhinolaryngology head and neck surgery. 17ª ed. Lewiston: BC Decker, 2009. p. 1005-11. ISBN 1-55009-337-7. MECANISMOS DE EVASAO IMUNE; CANCER DE CABECA E PESCOCO; PERDA DE CO-ESTIMULACAO DOS RECEPTORES; TERAPIA DO CANCER |
| 3/27 | US=8 / Laboratório Lecker SH, Saric T, Goldberg AL. Protein degradation in cells. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 34-41. ISBN 978-0-443-06715-0. DEGRADACAO DE PROTEINAS; PROTEOLISE LISOSSOMAL; CONJUGACAO DA UBIQUITINA; INIBIDORES DE PROTEASSOMA; TERAPIA DO CANCER; DEGRADACAO ASSOCIADA AO RETICULO ENDOPLASMATICO; PROTEOLISE EM MITOCONDRIA; QUEBRA DE PROTEINA MUSCULAR; CAQUEXIA |
| 4/27 | US=89 / Biol/Mol Feril Jr LB. Ultrasound-mediated gene transfection. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 179-94. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. ULTRA-SOM; TRANSFECCAO DO GENE; TERAPIA DO CANCER; HIFU; SONOTRANSFECCAO; ULTRA-SOM MEDIADA POR TRANSFECCAO |
| 5/27 | US=89 / Biol/Mol Simpson GR, Coffin RS. Construction and characterization of an oncolytic HSV vector containing a fusogenic glycoprotein and prodrug activation for enhanced local tumor control. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 551-64. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA DO CANCER; GLICOPROTEINA DE MEMBRANA FUSOGENICA (FMG); VIRUS HERPES SIMPLEX TIPO 1 (HSV-1); ONCOLITICOS; TERAPIA DE ATIVACAO PRO-DROGA |
| 6/27 | US=35 / Biol/Mol Bafico A, Grumolato L, Aaronson SA. Oncogenes and signal transduction. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 17-30. ISBN 978-1-4160-3703-3. ONCOGENE; TRANSDUCAO DE SINAL; RECEPTORES DE TIROSINA-QUINASE; RECEPTORES DE CITOCINA; NEUROTRANSMISSORES; SINALIZACAO WNT; TERAPIA DO CANCER |
| 7/27 | US=39 / Câncer Sarkar FH, Li Y. Sensitization of cancer cells to cancer therapies by isoflavone and its synthetic derivatives. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 327-35. ISBN 978-1-58829-989-5. SENSIBILIZACAO DAS CELULAS CANCEROSAS; TERAPIA DO CANCER; ISOFLAVONA; DERIVADOS SINTETICOS |
| 8/27 | US=47 / Câncer Kawabe T. Compounds that abrogate the G2 checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 117-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. CICLO CELULAR; G1; G2; ONCOGENESE; TERAPIA DO CANCER; DANOS AO DNA; REPARO DO DNA; MUTACAO |
| 9/27 | US=65 / Biol/Mol D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8. RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE |
| 10/27 | US=67 / Biol/Mol Thiagalingam S, Faller DV. The cancer epigenome: cann it be targeted for therapy?. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 97-113. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER; EPIGENOMA; METILACAO DO DNA; DNA METIL TRANSFERASE; HISTONA ACETILTRANSFERASE; HISTONA-DESACETILASE; CODIGO DE HISTONAS; CODIGO EPIGENOMICO ATIVA; CODIGO EPIGENOMICO SILENCIADO; INIBIDOR DE HISTONA-DESACETILASE; TERAPIA DO CANCER |
| 11/27 | US=67 / Biol/Mol Saini S, Hurwitz H. VEGF inhibition for cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 573-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. INIBICAO DO VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; TERAPIA DO CANCER; ANTI-ANGIOGENESE; INIBICAO DA QUINASE DE TIROSINA; BEVACIZUMABE; SORAFENIBE; BAY 43-9006; MALATO DE SUNITINIBE; SU11248; VATALANIBE |
| 12/27 | US=58 / Câncer Alao JP. G1 phase cyclins in cancer development and progression. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 123-53. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. FASE G1; CICLINAS EM CANCER; CICLO CELULAR; FASE G1; CICLINA D1; CICLINA E; CANCER; ONCOGENE; UBIQUITINA; PROTEASSOMA 26S; TERAPIA DO CANCER |
| 13/27 | US=84-A / Biol/Mol Wang GY, Hu XH, Zhang RM, Leach L, Luo ZW. Transformig growth factor-B in developing and advanced cancers: TGF-B ligands, TGF-B receptors, and lung cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 79-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. DNA METILACAO; CANCER DE PULMAO; TERAPIA DO CANCER; SMAD PROTEINAS; MUTACAO GENETICA; MIGRACAO DO TUMOR; TGF-B LIGANDOS; TGF-B RECEPTORES |
| 14/27 | US=84-A / Biol/Mol Datta PK, Mann JR. Development of inhibitors of transforming growth factor-B signaling for therapy: transforming growth factor-B (TGF-B) signaling inhibitors in cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 573-87. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; PEQUENA MOLECULA INIBIDORES; TRANSDUCAO DE SINAL; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; BIOMARCADOR; TERAPIA DO CANCER |
| 15/27 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 16/27 | US=86 / Biol/Mol Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 127-58. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RECEPTORES TRAIL; APOPTOSE; ANTICORPOS MONOCLONAIS |
| 17/27 | US=1 / Quimioterapia Esper P. Targeted therapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 57-75. ISBN 978-1-890504-68-7. TERAPIA-ALVO; TERAPIA DO CANCER; HISTORIA TERAPIAS-ALVO; EVOLUCAO DE TERAPIAS-ALVO; ALVO RECEPTORES DA SUPERFICIE CELULAR; PAPEL DO ENFERMEIRO DE ONCOLOGIA EM TERAPIA-ALVO; PACIENTE E EDUCACAO FAMILIAR |
| 18/27 | US=20 / Dor/Paliativo Fall-Dickson JM, Berger AM. Gastrointestinal symptoms and syndromes: oral manifestations and cancer complications of cancer therapy. In: Berger AM, Shuster Jr JL, von Roenn JH. Principles and practice of palliative care and supportive oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2007. p. 205-19. ISBN 0-7817-9595-8. CANCER; SINTOMAS GASTROINTESTINAIS; SINDROMES GASTROINTESTINAIS; MANIFESTACOES BUCAIS; COMPLICACOES ORAIS; TERAPIA DO CANCER; ESTOMATITE; OSTEONECROSE |
| 19/27 | US=46 / Câncer Reiter Y, Lev A. Immunotoxins and recombinant immunotoxins in cancer therapy. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 409-41. ISBN 978-3-527-31768-4. IMUNOTOXINAS; IMUNOTOXINAS RECOMBINANTES EM TERAPIA DO CANCER; TERAPIA DO CANCER; IMMUNOTOXINS; ANTICORPOS RECOMBINANTES; TERAPIA-ALVO |
| 20/27 | US=58 / Biol/Mol Shields AF, Price P. Role of imaging in cancer treatment. In: ___. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 1-12. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. TRATAMENTO DO CANCER. PAPEL DA IMAGEM; TERAPIA DO CANCER; CANCER DE IMAGENS; RESPOSTA AO TRATAMENTO DE IMAGENS; IMAGEM EM TRATAMENTO DE RADIOTERAPIA; DROGAS ANTICANCER |